Herbert Lepor, MD, and Danil V. Makarov, MD, MHS, continue discussing clinical options for a 58 year-old African American male with lower urinary tract symptoms in Part 2 of this episode of Curbside Consult. They explain the latest guidelines for preventive screening in prostate cancer from the United States Preventive Service Task Force and the American Urological Association. As they conclude the case, the experts also detail how to interpret PSA levels and under what circumstances to perform tissue biopsies.
Learn more about Herbert Lepor, MD.
Learn more about Danil V. Makarov, MD, MHS.
Related Reading
US Preventive Services Task Force (2012) Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 157(2):120-134.
